QUINOLINE COMPOUND SUSTAINED-RELEASE TABLET AND PREPARATION METHOD THEREFOR

Disclosed in the present invention is a quinoline compound sustained-release tablet, which contains the following raw and auxiliary materials in parts by weight: 1-40 parts of a quinoline compound, 100-300 parts of a filler, 50-200 parts of a sustained-release material and 0.5-4 parts of a lubricant...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KUANG, Tongtao, WEI, Xing, AI, Chaowu, LI, Xinghai, CHEN, Jiang
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed in the present invention is a quinoline compound sustained-release tablet, which contains the following raw and auxiliary materials in parts by weight: 1-40 parts of a quinoline compound, 100-300 parts of a filler, 50-200 parts of a sustained-release material and 0.5-4 parts of a lubricant. The filler comprises, but is not limited to, mannitol, microcrystalline cellulose, lactose, starch, corn starch, calcium hydrogen phosphate hydrate, magnesium carbonate, calcium carbonate, purified sucrose and/or glucose; the sustained-release material comprises, but is not limited to, hydroxypropyl methylcellulose, hydroxypropyl cellulose, and povidone, glyceryl behenate, and/or a long-chain fatty acid; and the lubricant comprises, but is not limited to, magnesium stearate, calcium stearate, sucrose fatty acid ester, sodium stearyl fumarate, polyethylene glycol, talc, glyceryl behenate and/or stearic acid.